Quantcast
Home / DC News / Studies spur FDA review of Yaz, other contraceptives

Studies spur FDA review of Yaz, other contraceptives

Safety review based on studies linking newer pills to higher blood clot risk

The Food and Drug Administration is conducting a safety review of birth control pills that contain drospirenone, such as Yaz, Yasmin, Beyaz and Ocella, after recent studies linked the drugs to a higher incidence of blood clots.